Diphtheria Global Clinical Trials Review, H2, 2017

Price :
Published : Jul-2017
No. of Pages : 219

Diphtheria Global Clinical Trials Review, H2, 2017


GlobalData’s clinical trial report, “Diphtheria Global Clinical Trials Review, H2, 2017” provides an overview of Diphtheria clinical trials scenario. This report provides top line data relating to the clinical trials on Diphtheria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Spectrum Pharmaceuticals Inc (SPPI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company's marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection); Zevalin (ibritumomab tiuxetan); Marqibo (vincristine sulfate liposome injection), Beleodaq (belinostat) and Evomela (Captisol-Enabled Melphalan). It also has drugs in mid-to-late stage development, namely, Rolontis (eflapegrastim) for chemotherapy-induced neutropenia; Qapzola (apaziquone) for Intravesical Instillation; and Poziotinib for the treatment of various types of cancers. The company markets its products through direct sales force in the US and through distributors in Europe. Spectr......

Goodwin Biotechnology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic filling and finishing, and cGMP manufacturing services. It also offers a range of mammalian cell culture development and manufacturing services. The company's support services comprise assay development, quality control, quality assurance, regulatory support and translational medicine and consulting services. It caters to various academic institutions, government agencies, biopharmaceutical companies and other sectors across the US. GBI is headquartered in Plantation, Florida, the US. Goo......

Karus Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Karus Therapeutics Ltd (Karus) is a designer and developer of molecule cancer therapies. The company provides treatment of a diverse range of solid and hematological cancers and small molecule drug. It develops two clinic-tracked programs potent and selective inhibitors of PI3K and HDAC for the treatment of inflammatory disease. Karus develops and markets medicines based on the potent and isoform-selective inhibition of two enzyme families such as histone deacetylase and PI3 kinase. The company's development programs offer medical needs in the fields of chronic inflammation, retaining drug design, immunotherapeutic modes, haematological malignancies and solid tumours. Its HDAC6 inhibitors are anti-tumour agents for the treatment of multiple myeloma. Karus is headquartered in Oxf......

KBI Biopharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products. The organization's service portfolio includes process development and cGMP manufacturing of recombinant protein active pharmaceutical ingredients, protein characterization, formulation, process design and development and testing. KBI also offers technology transfer, modeling and simulation and release testing and stability programs. The organization caters to clients worldwide to accelerate and optimize their drug development programs. It has offices in Durham, Boulder and The Woodlands. KBI is headquartered in Durham, North Carolina, the US. KBI Biopharma Inc - Pharmaceuticals & Hea......

Epic Pharma LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug company that develops and manufactures generic prescription drugs. The company's products include citalopram, betaxolol, amlodipine besylate, meperidine hydrochloride, flacoxate hydrochloride, nicardipine hydrochloride, guanfacine hydrochloride, sulindac, and ursodiol. It also offers contract manufacturing, encapsulation, tableting, packaging and testing services. Epic Pharma offers products in dosage forms of powder, capsule and tablet forms. It markets its products through its network of distributors. The company operates through manufacturing facility located in the US. Epic Pharma is headquartered in Laurelton, New York, the US. Epic Pharma LLC - Pharmaceuticals & Healthcare - Dea......

Nonlinear Dynamics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Nonlinear Dynamics Ltd (Nonlinear Dynamics), a subsidiary of Waters Corp is a data analysis software development company that provides analysis software products. The company offers products such as Progenesis CoMet that analyses LC-MS and GC-MS data to discover and quantify compounds. It research and develops proteomics analysis software, gel and data analysis software. Nonlinear Dynamics provides Progenesis LC MS, a data analysis program that enables to find and quantify the proteins. The company's products are used as application software that offers proteomics data for biomarker discovery using MALDI-TOF and SELDI analysis. Nonlinear Dynamics is headquartered in Newcastle upon Tyne, the UK. Nonlinear Dynamics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profil......

LegoChem Biosciences Inc (141080) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary LegoChem Biosciences Inc (LCB) is a drug company that research and develops small molecule drugs. The company's services include joint and contract research, chemical library package, compound synthesis and sales, and screening services. Its screening services include metabolic stability, plasma stability, protein binding, and cell toxicity. LCB also offers compound synthesis and process development services. The company manufactures drugs in the therapeutic areas of antibiotics, anticoagulants, anticancer and anti-inflammation. It conducts research programs through co-developments, joint researches, and global pharmaceutical companies. The company serves in different parts of Korea. LCB is headquartered in Daejeon, South Korea. LegoChem Biosciences Inc (141080) - Pharmaceuti......

ATUM – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ATUM, formerly DNA2.0 Inc is a bioengineering company that provide platforms for protein and vector engineering solutions. The company develops and offers synthetic biology solutions. Its products include expression vectors, electra system, CRISPR/Cas9, proteinpaintbox, cell strains and reagents. ATUM offers services such as gene synthesis, protein engineering, expression optimization, and vector engineering. The company provides antibody to developing enzymes for commercial drug and biofuel manufacture. It provides synthetic biology tools that include gene designer, GRNA designer, DNA atlas, bioinformatic, toolbox and literature database. The company serves academic, government and the pharmaceutical, chemical, agricultural and biotechnology industries. It operates through its ......

Foundation Medicine Inc (FMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas and others. It also offers additional materials, services, and real-time data through its technology products. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US. Foundation Medicine Inc (FMI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you com......

ImaBiotech SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that provides mass spectrometry imaging services. The organization offers software products such as multimaging and quantinetix. Its service portfolio includes consulting and training, biomarker discovery, pharmaco-kinetics and dynamics studies, screening studies, target engagement studies, and toxicology studies. ImaBiotech offers MALDI imaging services to therapeutic areas such as cardiovascular and metabolic diseases, central nervous system, dermatology and cosmetics, gastroenterology, and others. The organization provides consultancy and training services such as feasibility or protocol studies, cost and profitability; data storage, MALDI imaging mass spectrometry platform installation, project design, instrumen......